Quigley ALS Treatment Legislation Passes Key Legislative Milestone
The Accelerating Access to Critical Therapies for ALS Act, also known as ACT for ALS, legislation led by U.S. Representatives Mike Quigley (IL-05) and Jeff Fortenberry (NE-01), was advanced by the Energy and Commerce Subcommittee on Health by a voice vote. This marks a major advancement for the bill and brings it one step closer to a vote by the full House of Representatives. The legislation must now be approved by the full committee before consideration on the floor.
Following the Subcommittee approval, Quigley released the following statement:
“I am thrilled that ACT for ALS is at long last progressing through the legislative process. People diagnosed with fast-moving neurodegenerative diseases don’t have time to wait. ACT for ALS already has overwhelming support from Members as politically far apart as Louie Gohmert and Ilhan Omar for a reason, and now I’m grateful that it has received the full support of the Health Subcommittee,” said Quigley. “I am thankful to Health Subcommittee Chairwoman Anna G. Eshoo, and Ranking Member Brett Guthrie, as well as Energy and Commerce Chair Frank Pallone and Ranking member Cathy McMorris Rodgers, for their support in advancing this bill. Congressman Fortenberry and I will not rest until ACT for ALS is signed into law.”
ACT for ALS would help people living with ALS get early access to promising treatments and help researchers gain a better understanding of neurodegenerative diseases. The legislation has been cosponsored by 350 Members of Congress—including more than two thirds of the House, totaling 326 legislators—from across the political spectrum making it the most supported bill this Congress that has not yet gotten a floor vote.
Last month, Quigley spoke from the floor of the House about the urgent need to pass ACT for ALS. Video of those remarks is available HERE.